baber/WOPTO huggingface dataset:
Patent JP-2000503016-A (JP)
IPC: A61K47/32
Filed: 1997-01-03
Abstract: Granular materials are obtainable by pressing mixtures of at least one pulverulent, rheology-modifying, carboxyl-containing polymer as main component and at least one oil-soluble component.
Patent JP-2001523217-A (JP)
Title: 歯のエナメル質の再鉱化と鉱物質脱落予防用の方法および組成物
IPC: A61K8/24
Filed: 1996-06-05
Abstract: (57)【要約】
本発明は、口腔内に導入されるまでは互いに反応しない２相で存在する組成物を歯に適用することにより、歯のエナメル質の鉱物質脱落を伴わずに再鉱化させるという課題に関する。１相は少なくとも１種の水溶性カルシウム化合物を含有し、もう１つの相は少なくとも１種の無機リン酸塩と少なくとも１種の水溶性フッ素化合物とを含有する。このようにして、再鉱化を行うイオン類が歯のエナメル質に取り込まれ、続いて起こるそれらの反応で歯のエナメル質における鉱物質脱落部位の再硬化を生じる。
Patent JP-H10503082-A (JP)
IPC: A24B15/00
Filed: 1995-04-18
Abstract: PCT No. PCT/EP95/01452 Sec. 371 Date Oct. 17, 1996 Sec. 102(e) Date Oct. 17, 1996 PCT Filed Apr. 18, 1995 PCT Pub. No. WO95/28098 PCT Pub. Date Oct. 26, 1995Smokable products made of tobacco and/or another smokable material, which comprise natural substances having an antioxidative effect and/or naturally identical synthetic products thereof. These natural substances are selected according to the invention from hydroxycinnamic acids and their esters and depsides, plant phenols which can be derived from hydroxycinnamic acids, polymers of hydroxycinnamic alcohols, further natural substances of plant origin which have antimutagenic and aromatizing properties and are combined with vitamins, their precursors and/or derivatives having an antioxidative effect, and further vitamins having an antioxidative effect which are complexed with eukaryotic cell cultures. Processes for the preparation of products of this type are furthermore described. Compared with conventional smokable products, the products have a distinctly decreased risk potential.
Patent JP-2001511738-A (JP)
Title: 車両の横転傾向の検出方法および装置
IPC: B60R16/02
Filed: 1998-06-30
Abstract: (57)【要約】
本発明は、車両の縦方向に伸長する車両軸の周りにおける車両の横転傾向の検出のために使用される。このため、車両の縦方向動特性を表わす値が決定される。車両の縦方向に伸長する車両軸の周りにおける車両の横転傾向を検出するために使用される検出方式が、少なくとも車両の縦方向動特性を表わす値の関数として少なくとも２つの検出方式から選択され、および／または車両の縦方向に伸長する車両軸の周りにおける車両の横転傾向を検出するために使用される検出方式が、少なくとも車両の縦方向動特性を表わす値の関数として車両のそれぞれ存在する縦方向動特性に適合される。
Patent JP-2000506658-A (JP)
Title: データ構造の管理
IPC: H04L49/111
Filed: 1997-12-22
Abstract: (57)【要約】
電気通信の接続マップ等のデータ構造であって、メモリ装置（５２）の所定順序の場所に格納されたデータ要素のリストの少なくとも１つを備える。この構造内の特定の位置に新たな要素を挿入したり、あるいは、既存の要素を削除あるいは変更するため、所定順序の記憶場所を通って、リストの一部を移動することで、この構造を更新する一方、リストの順序を維持する。本構造の要素は、それらが格納された順序で読み出され、所定順序の記憶場所を介して要素を移動して、この構造にアクセスしている間に、構造が更新される。本発明に特有のアプリケーションは、電気通信スイッチの接続マップの維持であり、このマップは、どのＡＴＭセル・ペイロードに、受信した狭帯域呼データを組み立てるかを規定する接続命令を格納している。
Patent JP-H10501443-A (JP)
IPC: A61K47/04
Filed: 1996-03-20
Abstract: The present invention provides improved methods for manufacturing solutions including medical solutions. To this end, in an embodiment, a method for preparing a medical solution is provided comprising the steps of: placing a solution in a gas permeable container; and allowing carbon dioxide to permeate through the container until a desired pH is achieved.
Patent JP-H10500109-A (JP)
Title: 多発性硬化症のための組成物および治療方法
IPC: A61K39/00
Filed: 1995-05-04
Abstract: (57)【要約】
本発明は多発性硬化症（ＭＳ）を治療するための組成物および方法を提供する。本発明の組成物は、経口、皮下または静脈内投与のための適切な薬学的に許容される媒体中に、少なくとも１つのＴ細胞エピトープを含むミエリン塩基性タンパク質（ＭＢＰ）の少なくとも１種のペプチドまたは修飾ペプチド、およびＩＦＮ−βを含んでなる。本発明の方法は、ＭＳを有するかまたはＭＳに感受性であると疑われる個体を、本発明の組成物の治療的有効量を投与することによって、或いは治療的養生法において、少なくとも１つのＴ細胞エピトープを含むＭＢＰの少なくとも１種のペプチドまたは修飾ペプチドを含んでなる組成物を投与し、さらにＩＦＮ−βを投与することによって、治療することを含む。
Patent JP-2000506844-A (JP)
Title: 男性の相対及び絶対的アンドロゲン欠乏症を治療する医薬の製造に用いるデヒドロエピアンドロステロン及びアロマターゼ阻害剤の複合、並びにこの複合の使用
IPC: A61K31/565
Filed: 1997-03-06
Abstract: (57)【要約】
本発明は、男性の相対及び／又は絶対的アンドロゲン欠乏症を治療する医薬を製造するための、デヒドロエピアンドロステロン（ＤＨＥＡ）及び少なくとも１つのアロマターゼ阻害剤の複合、並びにこれらの複合の使用を記述する。発明の医薬を製造するために、例えば、アタメスタン、ホルメスタン、ペントロゾール、アリミデックス、ファドロゾール、ＣＧＳ20267及び／又はボロゾールなどの選択されたアロマターゼ阻害剤が、優先して使用される。
Patent JP-H11505211-A (JP)
IPC: C07K5/078
Filed: 1996-04-22
Abstract: This invention relates to derivatives of hemiasterlin or Geodiamolide G having anti-mitotic activities and useful in treating cancer. These derivatives are represented by general formula I, wherein Y, n, R1, R2, R3, R6, R7, R70, R71, R72, R74, and R75 are as defined in the specification.
Patent JP-2002511107-A (JP)
Title: 自由流動性の凝集したノニオン界面活性剤洗剤組成物及びその製法
IPC: C11D3/10
Filed: 1997-03-10
Abstract: (57)【要約】
自由流動性の凝集粉末洗剤の製法、並びに約５％〜約80％のアルキル金属炭酸塩、約５％〜約50％の洗剤界面活性剤、及び約25％までのカルボン酸のアルカリ金属塩（ここで、カルボン酸は、第１の温度より低い温度で対応するアルカリ金属塩の水溶性よりも大きい水溶性を有する。）を含む、該方法によって得られる組成物に関する。そのアルカリ金属塩は、好ましくは、（a）界面活性剤で被覆されたアルカリ金属炭酸塩を含有する予備混合物、（b）クエン酸、リンゴ酸、及びこれらの混合物からなる群より選ばれるカルボン酸、及び(c)水の反応でもっぱら提供される。
Patent JP-2001513900-A (JP)
Title: 改良固体フェーズ微量抽出方法及びデバイス
IPC: G01N1/10
Filed: 1998-12-16
Abstract: (57)【要約】
停留フェーズで少なくとも部分的に被膜した注射器の被膜内面でＳＰＭＥを行った後に続けて、分析のために、試料からガスクロマトグラフ注入器へのアナライトの脱離を行うための改良した方法及び装置。ＳＰＭＥ装置は、注射器バレル及びバレルの一方の端部内で滑動可能のプランジャを有する注射器、バレルの他方の端部から伸び、その内面に停留フェーズを被膜した中空針、及び前記中空針の内面と接触するように流体を送るための流体伝達手段、を含む。分析フェーズ中、キャリヤガスが、被膜内面と接触するように送られる。バルブ手段が、微量抽出フェーズ中の試料を含む容器から分析フェーズ中のキャリヤガスへ試料の流れをスイッチングするために使用される。本発明の好適実施例では、キャリヤガスは、分析フェーズ中に、注射器内を通過する前に、予め加熱される。
Patent JP-2001511090-A (JP)
Title: 例えば自動車の盗難防止装置に対するコード信号発生器
IPC: E05B49/00
Filed: 1998-01-07
Abstract: (57)【要約】
コード信号発生器（１０）がトランスポンダユニット（１００，１１０，１２０，１３０）を有し、該トランスポンダユニットは質問応答ダイアローグによって、発進阻止を解除するためにその正当性を証明する。さらにコード信号発生器は、遠隔操作ユニット（１２０，１４０，１６０，Ｓ４，Ｓ５）を有し、該遠隔操作ユニットはキー（Ｓ４，Ｓ５）の操作の際に制御信号をドアの開錠のために送信する。トランスポンダユニットも遠隔操作ユニットも、ただ１つの暗号化ユニット（１１０）を有し、該暗号化ユニットに前記２つのユニットが送信すべき信号を暗号化するためにアクセスする。
Patent JP-2001508075-A (JP)
Title: 硫黄含有２−クロロ−３−（４，５−ジヒドロ−３−イソキサゾリル）−安息香酸の製造法
IPC: C07D413/10
Filed: 1998-01-08
Abstract: (57)【要約】
置換基が明細書中に記載された意味を有する式Ｉの硫黄含有２−クロロ−３−（４，５−ジヒドロ−３−イソキサゾリル）−安息香酸は、明細書中の記載と同様に製造される。
Patent JP-H11505143-A (JP)
Title: 超弾性および可撓性を有する顎状部材組立体
IPC: A61B10/06
Filed: 1996-05-10
Abstract: (57)【要約】
内視鏡式生検用切断器用の顎状部材組立体（１２，１４）は超弾性を有する金属から作製された弾性を有するアーム（５０ａ，５０ｂ）を有する互いに反対側に位置する一対の端部作動体（４４ａ，４４ｂ）を有する。弾性を有するアーム（５０ａ，５０ｂ）の末端は端部作動体の顎状部材椀部（４６ａ，４６ｂ）として終端し、これら顎状部材椀部は好ましくは超弾性を有する金属から作製され、弾性を有するアーム（５０ａ，５０ｂ）の基部分（５１ａ，５１ｂ）は顎状部材椀部（４６ａ，４６ｂ）を互いに離すように角度をつけられた部分（５２ａ，５２ｂ）を有する。顎状部材椀部（４６ａ，４６ｂ）は互いに合わせられて鋭利な末端エッジ（４２）を有するシリンダ（４０）による噛みつき動作を行い、末端エッジは端部作動体（４４ａ，４４ｂ）のアーム（５０ａ，５０ｂ）に対して相対的に且つアーム上で動く。弾性を有するアーム（５０ａ，５０ｂ）が超弾性を有する金属から作製されるため、これらは多数回の使用の後でさえも非常に高い弾性と耐久性とを示す。
Patent JP-H10509596-A (JP)
Title: 組み換えバキュロウイルス殺虫剤
IPC: A01N63/40
Filed: 1996-05-16
Abstract: (57)【要約】
本発明は昆虫選択的神経毒をコードする遺伝子の至適な発現を提供するよう操作されている組み換えバキュロウイルスに関する。より特定しては、本発明は、レイウルス  キンケストリアツス  ヘブラエウス(Leiurus quinquestriatus hebraeus)由来のサソリ毒ＬｑｈＩＴ２をコードする単離された核酸配列に関する。ここで前述の配列は核多核体ウイルスに感染した細胞での遺伝子発現のために至適化されている。本発明はまた、コドンを至適化されたＬｑｈＩＴ２ヌクレオチド配列を含むキメラ遺伝子、コドンを至適化された昆虫選択的神経毒（例えばＬｑｈＩＴ２毒素遺伝子）を発現する組み換えバキュロウイルスを含む殺虫組成物、および、ＬｑｈＩＴ２毒素のような昆虫選択的神経毒をコードするコドンを至適化された核酸配列を含有する昆虫バキュロウイルスの適用を含む作物学的および非作物学的の双方の環境での昆虫の制御方法にも関する。
Patent JP-2000510003-A (JP)
IPC: A61P1/16
Filed: 1997-03-26
Abstract: A method of treating chronic HCV infections is disclosed. The method involves the optional treatment of a patient with interferon alpha and the treatment of a patient's blood with a psoralen compound followed by ultra violet light-activation of the psoralen compound. The blood treated as such is returned to the patient in a process known as extracorporeal photopheresis.
Patent JP-2002515740-A (JP)
Title: プレセニリン−２遺伝子の変種
IPC: C12Q1/6883
Filed: 1997-03-20
Abstract: (57)【要約】
本発明はプレセニリン−２遺伝子の変種を提供するものである。これらの遺伝子をアルツハイマー病の診断にて用いる方法もまた提供する。
Patent JP-2002500851-A (JP)
Title: 符号化データストリームのデータ変更方法及び装置
IPC: H04N7/26
Filed: 1999-02-11
Abstract: (57)【要約】
符号化データストリームを復号化し及び再符号化する基本トランスコーダを、そのストリームの部分的に変更するデータに対して用いる。その変更を、所定の変更するデータストリームに基づいて、予測されるデータストリームを規定するとともに、トランスコーダの復号化部及び再符号化部との間で復号化されたストリームに、変更するデータストリームと予測されるデータストリームとの間の差を加算することによって行う。向上した実現において、変更するデータストリームを再処理して、復号化したデータストリーム中に、復号化したデータに対する変更するデータの部分的な差を得る。
Patent MX-159403-A (MX)
Inventor: MOLLER THOMAS ALLEN
IPC: E21B43/26
Filed: 1982-03-15
Abstract: A telescoping boom assembly supported articulated well service pipeline (10) for the transfer of pressurized fluids from service vehicles to petroleum wellheads for the treatment and stimulation of production oil wells. The boom assembly (12) is mounted on a truck, trailer, or other suitable mobile transport, and the articulated pipeline (11) comprises a pair (16), (17) of long straight end pipe sections interconnected by a plurality (18), (19), (20) of shorter intermediate pipe sections and by swivel joints (25). The two end pipe sections are aligned generally parallel with the telescoping boom and the intermediate pipe sections flip-flop to change their direction of alignment as the pipeline is extended and retracted. The flip-flop feature provides a maximum change in length of the pipeline between the extended and the retracted positions with a minimum number of pipe swivel joints.
Patent NZ-191482-A (NZ)
Title: 9-(1-alkyl-2-hydroxyprop-1-yl)-1,9-dihydro-6h-purin-6-ones
Inventor: GINER-SOROLLA A
IPC: C07D473/30
Filed: 1979-09-05
Abstract: There are prepared compounds of the formula  <IMAGE>  where X is OH, R2 is CH3 and R1 is alkyl of 1 to 8 carbon atoms. The compounds are immunopotentiators, have antiviral activity and anti-leukemic activity.
Patent NZ-194992-A (NZ)
Title: Skin care composition containing an amine salt of fatty alcohol sulphate
Inventor: HERMANN C
IPC: C11D1/29
Filed: 1980-09-18
Abstract: A bath additive or shower gel, comprising 20 to 70% by weight of a detergent blend (consisting of 10 to 90% by weight of an amine C8-18 fatty alcohol sulphate (optionally ethoxylated) and a metal or ammonium ethoxylated C8-18 fatty alcohol sulphate) and 20 to 60% by weight of a cosmetically acceptable oil, gives improved oil deposition.
Patent NZ-201142-A (NZ)
Title: Termite bait containing boron-containing toxicant
Inventor: D ORAZIO V T
IPC: A01N25/08
Filed: 1982-07-02
Abstract: Termite baits utilizing brown rot fungus as an attractant and utilizing boron compounds selected from colemanite, ulexite and calcium boride in mixtures effectively sufficient to kill termites without creating bait shyness.
Patent NZ-203802-A (NZ)
Title: Pharmaceutical compositions with a perfluorohydrocarbon vehicle
Inventor: YORK B M
IPC: A61K31/02
Filed: 1983-04-06
Abstract: Perfluorohydrocarbons are used as vehicles for administering therapeutic drugs.
Patent NZ-220945-A (NZ)
Title: Pump chamber dispenser
Inventor: BALL M F
IPC: B65D47/34
Filed: 1987-07-03
Abstract: A pump chamber dispenser for toothpaste or other viscous or pasty product comprises a pump member (54) moulded from elastomeric material and having a domed central portion (56) and a bifurcated peripheral portion providing inner and outer skirts arranged to lie against respective surfaces of a projection (36) formed on the end wall (18) of the dispenser body (10), and to serve as inlet and exit valves controlling an inlet port (20) communicating the pump chamber (21) with the reservoir chamber (22), and an exit port communicating the pump chamber with a discharge nozzle (68). The nozzle is integral with a cover fixed to the body (10) and enclosing the pump member, the cover including a button (70) for acting on the pump member to operate the dispenser.
Patent NZ-221425-A (NZ)
Title: Envelope with translucent panel: tear off portion provided opposite closure flap
Inventor: BRUNJES GERALD A E
IPC: B65D27/04
Filed: 1987-08-12
Abstract: An envelope suitable for use in automatic teller machines is composed of two separate sheets of material forming a rectangular front panel l0 and a rectangular back panel 20 respectively. The front panel l0 and back panel 20 are adhesively secured along three marginal edges l2,l3,l4 and a closure flap l5 extends from the front panel l0 along its unsecured edge ll. The surface of the closure flap facing the back panel carries an adhesive substance l6 whereby the closure flap may be folded along the said unsecured edge ll over the back panel 20 and secured thereto to close and seal the envelope. The material of one of the panels is a translucent paper receptive to conventional printing processes and adapted to permit visual inspection of the envelope contents when the envelope is sealed.
Patent NZ-232980-A (NZ)
Title: (((1,3,5-triazin-2-yl)aminocarbonyl)aminosulphonyl) benzoic esters and herbicidal compositions
Inventor: MAYER HORST
IPC: C07D521/00
Filed: 1990-03-19
Abstract: [[(1,3,5-Triazin-2-yl)aminocarbonyl]aminosulfonyl]benzoic esters of the general formula I   <IMAGE> I  wherein R1 and R2 are methyl or ethyl, and R3 is hydrogen, fluorine or chlorine, agriculturally useful salts thereof, processes for their manufacture, and their use.
Patent NZ-240789-A (NZ)
Title: Guanidine derivatives and cyclised analogues, preparation and pharmaceutical compositions
Inventor: MALEN CHARLES
IPC: A61K31/495
Filed: 1991-11-28
Abstract: Compounds of general formula (I): <IMAGE>  in which:   R1 denotes a substituted or unsubstituted phenyl group or a cycloalkyl (C3-C7) group,   R2 denotes a trifluoromethyl or cycloalkyl (C3-C4) group,   A denotes a -CH2-, -CH=N-, =N- or -NH- group, R3 and R4, which are identical or different, denote a hydrogen atom, a linear or branched alkyl (C1-C6) group, or form, with the nitrogen atoms to which they are attached, a 5- or 6-membered heterocyclic ring, R denotes either a hydrogen atom in the case where A = -CH2-, -CH=N- or -NH-, or a bond of the group A when the latter is equal to =N-, their enantiomers and epimers and their addition salts with a pharmaceutically acceptable acid. Medications.
Patent NZ-243279-A (NZ)
Title: Sediment removal apparatus for sewage treatment having inclined raking sieve worm and sand classifying worm on common shaft
Inventor: HUBER HANS GEORG
IPC: E03F5/14
Filed: 1992-06-23
Abstract: A sand collector for separating out and removing sand from feeders, in particular of sewage treatment plants, is provided with a settling channel (1) running as a straight section and having an in particular trapezoidal cross-section. A conveyor (8) operating against the direction of flow is provided in the vicinity of the bottom (6). A classifying conveyor (10) delivers the sand transferred from the conveyor (8) upwardly at an incline. The classifying conveyor (10) is arranged in the central longitudinal plane (5) of the settling channel (1). It is equipped with a discharge chute (17) which can be used on the left or right as desired. <IMAGE>
Patent NZ-262804-A (NZ)
Title: Medical waste disposal system of grinding waste with anti-microbial material in a chamber
Inventor: KRALOVIC RAYMOND C
IPC: A01N31/08
Filed: 1994-02-25
Abstract: A bag (86) of medical wastes is inserted into a chamber (12) that contains a grinder (20). A package (48) is placed unopened in the chamber with the medical wastes. A selected volume of a dilutant such as water is added to the chamber (40, 42). The chamber is closed and the grinder operated for a selected duration. The grinder grinds the packaging, disposing of the packaging and permitting contained dry reagents (56, 58) such as acetylsalicylic acid and perborate to react with the dilutant, forming a peracetic acid solution or permitting a sterilant concentrate (70) to form an anti-microbial solution with the dilutant. The grinder continues to grind the packaging and the medical wastes into fine particulates forming a slurry with the peracetic acid solution. The continued operation of the grinder assures that the anti-microbial solution contacts all surfaces of the waste. In this manner, the medical wastes are microbially decontaminated. A color indicator (60, 78) is included with the packaging to provide a color indication as to whether the anti-microbial reaction is complete. For example, a Gentian Violet may be provided which fades to white to indicate completion of the decontamination process. Once decontaminated, the slurry is removed from the chamber and disposed of as non-contaminated waste materials. Optionally, fragrances and deodorants may be included in the package.
Patent NZ-266353-A (NZ)
Title: Absorbent article; side flaps tucked into recesses and releasably secured thereto
Inventor: LAVASH BRUCE WILLIAM
IPC: A61F13/15
Filed: 1994-05-04
Abstract: An absorbent article having a main body portion and a pair of flaps joined to the main body portion. The main body portion comprises an absorbent assembly and a pair of retaining members joined to the absorbent assembly to form recessed areas wherein the flaps may be tucked. Each retaining member comprises a unitary release material joined thereto such that the unitary release material superposes and is releasably secured to the flap adhesive when the flap is folded and tucked into the recessed area.
Patent NZ-279292-A (NZ)
Title: Aminocyclohexane derivatives in pharmaceutical compositions for use as voltage-gated potassium channel blockers
Inventor: CROSSLEY ROGER
IPC: A61P25/00
Filed: 1995-02-10
Abstract: PCT No. PCT/GB95/00280 Sec. 371 Date Jul. 15, 1996 Sec. 102(e) Date Jul. 15, 1996 PCT Filed Feb. 10, 1995 PCT Pub. No. WO95/21813 PCT Pub. Date Aug. 17, 1995This invention concerns compounds of generic formula:    <IMAGE>  (I)  or a pharmaceutically acceptable salt thereof, where the dotted line represents an optional bond, one of R1 and R5 represents hydrogen, C1-C6 alkyl, C7-C16 aralkyl, -(CHR6)nCHR7CN, -(CHR6)nCHR7CONH2, -(CHR6)nCHR7COOR8, -(CHR6)nCHR7CH2OH wherein n is 0 or 1, R6 and R7 independently represent hydrogen, C1-C6 alkyl- or C7-C16 aralkyl-, and R7 also represents hydroxy(C1-C6)alkyl-, (C2-C7)alkanoyloxy(C1-C6)alkyl-, (C1-C6alkoxy)carbonyl- and R8 is hydrogen or C1-C6 alkyl; the other of R1 and R5 is hydrogen, C1-C6 alkyl or C7-C16 aralkyl; R3 is C6-C10 aryl or heteroaryl group optionally substituted by one or more substituents the same or differnet, R2 and R4 independently represent hydrogen, or a group of formula -CRaRbRc where Ra, Rb and Rc are independently selected from hydrogen, C1-C6 alkyl, optionally substituted C6-C10 aryl, optionally substituted heteroaryl, C1-C6 alkyl substituted by optionally substituted C6-C10 aryl or heteroaryl or R2 also represents COR11 where R11 is C1-C6 alkyl, C1-C6 alkoxy or an optionally substituted (C6-C10 aryl)alkyl or a heteroaryl alkyl radical; one of Y and Y1 is   <IMAGE>   where R13 represents hydrogen, C1-C6 alkyl or C7-C16 aralkyl; the other of Y and Y1 is -CHR12- where R12 is hydrogen, C1-C6 alkyl or C7-C16 aralkyl, which compounds have pharmaceutical uses conferred by their ability to block voltage gated potassium channels.
Patent NZ-301665-A (NZ)
Title: Magnetorelaxometric detection of analytes
Inventor: WEITSCHIES WERNER
IPC: G01N33/532
Filed: 1996-01-29
Abstract: PCT No. PCT/EP96/00339 Sec. 371 Date Feb. 23, 1998 Sec. 102(e) Date Feb. 23, 1998 PCT Filed Jan. 29, 1996 PCT Pub. No. WO96/23227 PCT Pub. Date Aug. 1, 1996The invention relates to a process for magnetorelaxometric quantitative detection of analytes in liquid and solid phases, compounds for magnetorelaxometric detection, and their use in analysis and immunomagnetography.
Patent NZ-306583-A (NZ)
Title: Universal card interface translates high level code to card level code
Inventor: ZUPPICICH ALAN NOEL
IPC: G06K17/00
Filed: 1996-05-09
Abstract: card reader/writer interfaces between a host application program and a data storage card. The card reader/writer reads from and writes to the application program with high level language of the commands. The card reader/writer translates the high level language commands of the host program to corresponding sequences of low level commands for reading and writing to the data storage card. The card reader/writer stores a plurality of sets of such low level commands, and is able to establish the card type for any card interfaced with the card reader/writer, and to use the appropriate command set for the established card type. The card reader/writer also translates low level commands from the card to high level commands for the host application program. The card reader/writer can be loaded with low level command sets for additional card types as required.
Patent NZ-312229-A (NZ)
Title: Cross-linked biocompatible polysaccharide gel composition
Inventor: AGERUP BENGT
IPC: C08B37/08
Filed: 1996-05-28
Abstract: The present invention provides a process for preparing a cross-linked biocompatible polysaccharide gel composition, which comprises: forming an aqueous solution of a water soluble, cross-linkable polysaccharide; initiating a cross-linking of said polysaccharide in the presence of a polyfunctional cross-linking agent therefor; sterically hindering the cross-linking reaction from being terminated before gelation occurs, an activated poly-saccharide being obtained; and reintroducing sterically unhindered conditions for said activated polysaccharide so as to continue the cross-linking thereof to a viscoelastic gel. The invention also provides a gel composition obtainable by such a process as well as gel compositions for different medical uses.
Patent NZ-328321-A (NZ)
Title: Hand held in line electric water heater for killing weeds, power supply to elements thermostatically controlled
Inventor: WEATHERLY JOHN DEANE
IPC: B05B1/24
Filed: 1998-07-10
Abstract: A hand-held spray wand, used for killing weeds with boiling water incorporates a thermostatically controlled in-line electric water heater.  The heater incorporates two elements 107 and 109.  One element, 107, provides most of the heat energy, while the other element 109 is controlled by thermostat 108 to maintain the outlet water temperature at 95 - 100‹C.  Water passes through the element 107 first, and then the second.  An electronic controller may be used instead of the thermostat.
Patent NZ-332112-A (NZ)
Title: Wound dressings incorporating absorbent fibres comprising calcium alginate and cellulose
Inventor: KERSHAW DAVID
IPC: A61L15/16
Filed: 1997-04-11
Abstract: This wound dressing comprises 50% to 95% by weight of discrete textile fibres and 5% to 50% by weight of discrete absorbent composite fibres.  The textile fibres can be polyester, polypropylene or polyamide.   The absorbent composite fibres comprise a matrix of 10% to 50% of calcium or sodium alginate, and at least 40% of another polysaccharide.  This polysaccaride is selected from carboxymethyl cellulose, carboxyethyl cellulose, cellulose, pectin, hyaluronic acid and chitosan.
Patent NZ-334638-A (NZ)
Title: Mammary gland-specific promoters consisting of neu-related lipocalin (NRL) or neutophil gelatinase associated lipocalin (NGAL).
Inventor: GOULD MICHAEL N
IPC: C12N15/85
Filed: 1997-05-05
Abstract: An isolated DNA fragment comprising a mammary gland-specific promoter selected from the group consisting of neu-related lipocalin (NRL) or neutrophil gelatinase associated lipocalin (NGAL) is disclosed. Preferably, this promoter promotes gene expression throughout the estrous cycle in a constant manner. In one embodiment, the promoter comprises nucleotides 1154 through 2967 of SEQ ID NO:1 or 1102 through 2910 of SEQ ID NO:2.  Also claimed is a transgenic non-human animal comprising said isolated DNA fragment and promoter.
Patent NZ-502814-A (NZ)
Title: Use of the lighter and less viscous virgin naphtha to facilitate nitrogen removal from natural gas
Inventor: CICCARELLI LIBERATO
IPC: B01D53/14
Filed: 2000-02-11
Abstract: A process for the removal of nitrogen contained in natural gas is described.  The process comprises: 1. absorbing the hydrocarbon component of natural gas by means of virgin naphtha, a petroleum cut essentially consisting of C5-C8 paraffins, in an absorption device, discharging the non-absorbed nitrogen; 2. stripping the hydrocarbon component from the virgin naphtha in a stripping column operating at a temperature at the bottom ranging from 150-200 degrees Celsius; 3. recycling the virgin naphtha, recovered in the stripping, to step 1; 4. feeding the stripped hydrocarbon component to a distribution network. The natural gas containing nitrogen (1), pretreated to eliminate humidity, carbon dioxide and other gases such as H2S, is fed to the base of the absorption column (D1).  The virgin naphtha is fed to the head of the column (D1) by means of a feeding line (2).  The virgin naphtha is generally recycled virgin naphtha (12).
Patent NZ-504375-A (NZ)
Title: Adamantane derivatives
Inventor: CLADINGBOEL DAVID
IPC: C07D295/092
Filed: 1998-12-01
Abstract: P2X7 receptors (also known as P2Z receptors) are ligand-gated ion channels that can lead to the release of interleukins.  P2X7 receptor antagonist compounds of formula (I) can be used to treat inflammatory conditions.